Viatris (VTRS) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $18.22, +4.47% vs the prior close of $17.44.
- Volume 8.38M shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
VTRS jumps 4.5% to $18.22. Closed at $18.22, +4.47% vs the prior close of $17.44. Day range $17.70–$18.24, opened at $17.75.
VTRS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — VTRS jumps 4.5% to $18.22
- Closed at $18.22, +4.47% vs the prior close of $17.44. Day range $17.70–$18.24, opened at $17.75.
- Volume was 8.38M shares, 0.9x its 50-day average of 9.20M.
- Price is +7.6% vs its 50-day average ($16.93) and +17.0% vs its 200-day average ($15.57).
- 52-week range $9.86–$18.43; today's close sits at 98% of that range, 1.1% below the 52-week high.
Oct 14, 2026 — VTRS rises 1.1% to $17.44
- Closed at $17.44, +1.10% vs the prior close of $17.25. Day range $17.24–$17.82, opened at $17.27.
- Volume was 8.68M shares, 0.9x its 50-day average of 9.21M.
- Price is +3.1% vs its 50-day average ($16.92) and +12.2% vs its 200-day average ($15.54).
- 52-week range $9.73–$18.43; today's close sits at 89% of that range, 5.4% below the 52-week high.
Oct 13, 2026 — VTRS dips 1.7% to $17.25
- Closed at $17.25, -1.65% vs the prior close of $17.54. Day range $17.21–$17.66, opened at $17.66.
- Volume was 7.55M shares, 0.8x its 50-day average of 9.23M.
- Price is +1.9% vs its 50-day average ($16.92) and +11.2% vs its 200-day average ($15.51).
- 52-week range $9.73–$18.43; today's close sits at 86% of that range, 6.4% below the 52-week high.
Oct 12, 2026 — VTRS dips 0.6% to $17.54
- Closed at $17.54, -0.57% vs the prior close of $17.64. Day range $17.53–$17.79, opened at $17.70.
- Volume was 7.55M shares, 0.8x its 50-day average of 9.39M.
- Price is +3.6% vs its 50-day average ($16.93) and +13.2% vs its 200-day average ($15.49).
- 52-week range $9.69–$18.43; today's close sits at 90% of that range, 4.8% below the 52-week high.
Oct 9, 2026 — VTRS rises 1.1% to $17.64
- Closed at $17.64, +1.15% vs the prior close of $17.44. Day range $17.19–$17.76, opened at $17.36.
- Volume was 8.83M shares, 0.9x its 50-day average of 9.33M.
- Price is +4.2% vs its 50-day average ($16.93) and +14.1% vs its 200-day average ($15.46).
- 52-week range $9.69–$18.43; today's close sits at 91% of that range, 4.3% below the 52-week high.
Oct 8, 2026 — VTRS ends flat (-0.3%) to $17.44, 3 down days in a row
- Closed at $17.44, -0.29% vs the prior close of $17.49. Day range $16.89–$17.52, opened at $17.26.
- Volume was 14.11M shares, 1.5x its 50-day average of 9.25M.
- Price is +3.0% vs its 50-day average ($16.94) and +13.0% vs its 200-day average ($15.43).
- 52-week range $9.69–$18.43; today's close sits at 89% of that range, 5.4% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 8-K.
Oct 7, 2026 — VTRS ends flat (-0.3%) to $17.49
- Closed at $17.49, -0.29% vs the prior close of $17.54. Day range $17.41–$17.82, opened at $17.52.
- Volume was 7.54M shares, 0.8x its 50-day average of 9.29M.
- Price is +3.2% vs its 50-day average ($16.94) and +13.5% vs its 200-day average ($15.41).
- 52-week range $9.69–$18.43; today's close sits at 89% of that range, 5.1% below the 52-week high.
Oct 6, 2026 — VTRS dips 0.5% to $17.54
- Closed at $17.54, -0.45% vs the prior close of $17.62. Day range $17.31–$17.87, opened at $17.77.
- Volume was 6.68M shares, 0.7x its 50-day average of 9.35M.
- Price is +3.5% vs its 50-day average ($16.95) and +14.1% vs its 200-day average ($15.38).
- 52-week range $9.69–$18.43; today's close sits at 90% of that range, 4.8% below the 52-week high.
Oct 5, 2026 — VTRS ends flat (+0.1%) to $17.62
- Closed at $17.62, +0.11% vs the prior close of $17.60. Day range $17.45–$17.91, opened at $17.82.
- Volume was 6.36M shares, 0.7x its 50-day average of 9.37M.
- Price is +3.9% vs its 50-day average ($16.95) and +14.8% vs its 200-day average ($15.35).
- 52-week range $9.69–$18.43; today's close sits at 91% of that range, 4.4% below the 52-week high.
Oct 2, 2026 — VTRS rises 0.8% to $17.60
- Closed at $17.60, +0.80% vs the prior close of $17.46. Day range $17.34–$17.65, opened at $17.53.
- Volume was 7.53M shares, 0.8x its 50-day average of 9.38M.
- Price is +3.9% vs its 50-day average ($16.94) and +14.9% vs its 200-day average ($15.32).
- 52-week range $9.69–$18.43; today's close sits at 91% of that range, 4.5% below the 52-week high.
VTRS latest news & SEC filings
Every SEC filing by or about VTRS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 8, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 8.01 — Reported other events the company considers important.
Oct 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 8, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 18, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 12, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $3.75B (prior year $3.57B) (+5.0% vs Jun 30, 2025)
- Diluted EPS: -$0.10 (prior year $0.00)
Aug 6, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 8.01 — Reported other events the company considers important.
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 1, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 1, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 1, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
Jun 26, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Campbell Paul sold 50,076 shares at $16.17 (≈$809.73K) on Jun 25, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Things to know before you trade VTRS
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Feb 26, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.24% (largest 4.5%).
- Liquidity: about 9.44M shares (≈$172.06M) trade per day on average.
- 52-week position: $18.22 vs a range of $9.86–$18.43 (98% of the range).
- Dividends: last ex-dividend date Aug 21, 2026 ($0.12/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 2 open-market buys, 2 sales; latest: Paul Campbell sold 50,076 shares on Jun 25, 2026.
- Latest filings: 8-K Oct 8, 2026; 10-Q Aug 6, 2026; 8-K Aug 6, 2026.
- Share count: 1.15B shares outstanding (Aug 3, 2026), -1.5% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
VTRS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 17.75 | 18.24 | 17.70 | 18.22 | 8.38M |
| Oct 14, 2026 | 17.27 | 17.82 | 17.24 | 17.44 | 8.68M |
| Oct 13, 2026 | 17.66 | 17.66 | 17.21 | 17.25 | 7.55M |
| Oct 12, 2026 | 17.70 | 17.79 | 17.53 | 17.54 | 7.55M |
| Oct 9, 2026 | 17.36 | 17.76 | 17.19 | 17.64 | 8.83M |
| Oct 8, 2026 | 17.26 | 17.52 | 16.89 | 17.44 | 14.11M |
| Oct 7, 2026 | 17.52 | 17.82 | 17.41 | 17.49 | 7.54M |
| Oct 6, 2026 | 17.77 | 17.87 | 17.31 | 17.54 | 6.68M |
| Oct 5, 2026 | 17.82 | 17.91 | 17.45 | 17.62 | 6.36M |
| Oct 2, 2026 | 17.53 | 17.65 | 17.34 | 17.60 | 7.53M |
| Oct 1, 2026 | 17.62 | 17.84 | 17.43 | 17.46 | 9.04M |
| Sep 30, 2026 | 18.16 | 18.17 | 17.71 | 17.72 | 11.81M |
| Sep 29, 2026 | 18.25 | 18.43 | 17.87 | 18.12 | 13.86M |
| Sep 28, 2026 | 17.75 | 18.37 | 17.54 | 18.27 | 12.38M |
| Sep 25, 2026 | 17.52 | 17.98 | 17.37 | 17.83 | 10.15M |
| Sep 24, 2026 | 17.05 | 17.45 | 17.00 | 17.42 | 13.74M |
| Sep 23, 2026 | 17.26 | 17.60 | 16.99 | 17.12 | 6.87M |
| Sep 22, 2026 | 17.10 | 17.23 | 16.98 | 17.18 | 5.24M |
| Sep 21, 2026 | 16.98 | 17.35 | 16.87 | 17.10 | 6.93M |
| Sep 18, 2026 | 17.19 | 17.20 | 16.91 | 16.95 | 15.65M |
About Viatris
Viatris (VTRS) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in CANONSBURG, PA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1792044.
VTRS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| W Don Cornwell | Director | Mar 10, 2026 |
| Frank A Damelio | Director | Mar 10, 2026 |
| Elisha W Finney | Director | Mar 10, 2026 |
| Leo Frans Groothuis | Director | Jul 1, 2026 |
| Melina E Higgins | Director | Mar 10, 2026 |
| James M Kilts | Director | Mar 10, 2026 |
| Dillon Joellen Lyons | Director | Mar 10, 2026 |
| Richard A Mark | Director | Mar 10, 2026 |
| Mark W Parrish | Director | Mar 10, 2026 |
| Michael Severino | Director | Mar 10, 2026 |
| David S Simmons | Director | Jul 1, 2026 |
| Scott Andrew Smith | Chief Executive Officer | Mar 10, 2026 |
| Coelho Rogerio Vivaldi | Director | Mar 10, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Paul Campbell | See Remarks | Jun 26, 2026 |
| Andrew Enrietti | See Remarks | Aug 18, 2026 |
| Goff Corinne Le | Chief Commercial Officer | Apr 16, 2026 |
| Matthew Joseph Maletta | Chief Legal Officer | Mar 10, 2026 |
| Theodora Mistras | Chief Financial Officer | Mar 10, 2026 |
| Scott Andrew Smith | Chief Executive Officer | Mar 10, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 25, 2026 | Paul Campbell | Sale | 50,076 | $16.17 |
| Mar 23, 2026 | Paul Campbell | Sale | 21,350 | $13.28 |
| Nov 3, 2025 | David S Simmons | Buy | 213 | $10.43 |
| Aug 27, 2025 | David S Simmons | Buy | 286 | $10.42 |
VTRS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $14.25B | — | -3.00 | $2.32B |
| Dec 31, 2024 | $14.69B | — | -0.53 | $2.30B |
| Dec 31, 2023 | $15.39B | — | 0.05 | $2.90B |
| Dec 31, 2022 | $16.22B | — | 1.71 | $3.00B |
| Dec 31, 2021 | $17.81B | — | -1.05 | $3.02B |
Latest balance sheet: total assets $35.04B, total liabilities $20.78B, cash $886.50M (as of Jun 30, 2026).
VTRS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $16.29 |
| May 7, 2026 | 8-K Item 2.02 (results) | $17.39 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $15.25 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $10.11 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $9.39 |
| May 8, 2025 | 8-K Item 2.02 (results) | $9.09 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $9.53 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $13.18 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Feb 28, 2024 | 8-K Item 2.02 (results) | — |
| Nov 7, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on VTRS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.